Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Jodi Speiser"'
Publikováno v:
JAAD Case Reports, Vol 47, Iss , Pp 115-117 (2024)
Externí odkaz:
https://doaj.org/article/cf4c3481d3f648c2bf7a452f58ec6143
Autor:
Angela Jiang, MD, Itisha S. Jefferson, BS, S. Kayo Robinson, MD, Dana Griffin, MD, William Adams, PhD, Jodi Speiser, MD, Laura Winterfield, MD, MPH, Anthony Peterson, MD, Eleanor Tung-Hahn, Kristin Lee, MD, David Surprenant, MD, Anne Coakley, BS, Rebecca Tung, MD, Murad Alam, MD, MSCI, MBA
Publikováno v:
International Journal of Women's Dermatology, Vol 7, Iss 4, Pp 411-414 (2021)
Background: Patients presenting with a site-specific skin complaint may receive a total body skin examination (TBSE) or a more focused examination. A TBSE may be time-consuming but can potentially detect unsuspected or early stage skin cancers. The p
Externí odkaz:
https://doaj.org/article/9f46f33e4ae04980b247e4ad3b8ae187
Autor:
Michael Sadek MD, Omer Iqbal MD, Fakiha Siddiqui BDS, Sean Till MD, Melissa Mazariegos BS, Edward Campbell PhD, Kumaran Mudaliar MD, Jodi Speiser MD, Emily Bontekoe BS, Ahmed Kouta RPH, Ambar Farooqui MD, Bharathi Daravath MD, Dalia Qneibi MD, Ramy Sadek MD, Debra Hoppensteadt PhD, Jawed Fareed PhD, Charles Bouchard MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are Severe Cutaneous Adverse Reactions (SCARS) characterized by fever and mucocutaneous lesions leading to necrosis and sloughing of the epidermis. Conjunctival lesions are reported
Externí odkaz:
https://doaj.org/article/c2884957fbfa4ecba25da5c0f27f36ab
Autor:
Kirsten C. Webb, Magdalena Harasimowicz, Monica Janeczek, Jodi Speiser, James Swan, Rebecca Tung
Publikováno v:
Case Reports in Dermatological Medicine, Vol 2017 (2017)
Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) used to treat imatinib-resistant chronic myelogenous leukemia (CML), as well as other Philadelphia chromosome-positive lymphoproliferative disorders. While the most commonly reported cu
Externí odkaz:
https://doaj.org/article/8e12fa0e610149fb93d1d7e6520395bb
Autor:
Mario L. Marques‐Piubelli, Riyad N. H. Seervai, Kumaran M. Mudaliar, Wencai Ma, Denái R. Milton, Jing Wang, Aaron Muhlbauer, Edwin R. Parra, Luisa M. Solis, Priyadharsini Nagarajan, Jodi Speiser, Courtney Hudgens, Woo Cheal Cho, Phyu P. Aung, Anisha Patel, Omar Pacha, Kelly C. Nelson, Michael T. Tetzlaff, Rodabe N. Amaria, Carlos A. Torres‐Cabala, Victor G. Prieto, Ignacio I. Wistuba, Jonathan L. Curry
Publikováno v:
Journal of Cutaneous Pathology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14bce609e0cc20e6dc985c43ae9e8282
https://doi.org/10.1111/cup.14442
https://doi.org/10.1111/cup.14442
Publikováno v:
Journal of Cutaneous Pathology. 49:632-637
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f08f074cea6b67a75a5ab56892a6e84c
https://doi.org/10.1111/cup.14213
https://doi.org/10.1111/cup.14213
Autor:
Milind Velankar, Aaron Muhlbauer, Brandon Zelman, Mariam Mafee, Kamran M. Mirza, Olaoluwa Bode-Omoleye, Ada Agidi, Jodi Speiser, Kumaran Mudaliar
Publikováno v:
Journal of Cutaneous Pathology. 48:1277-1281
While drug-induced panniculitis is not uncommon in chronic myeloid leukemia (CML) patients on tyrosine kinase inhibitor therapy, it is rare for CML to initially present as a leukemic panniculitis. We present the case of a 45-year-old male with no rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cfca8b55695d1425b188bb12f50dfc5
https://doi.org/10.1111/cup.14030
https://doi.org/10.1111/cup.14030
Publikováno v:
Journal of Cutaneous Pathology. 48:1320-1323
Hand-foot syndrome (HFS), also known as palmar-plantar erythrodysesthesia (PPE), is a localized cutaneous adverse event (CAE) associated with a variety of chemotherapeutic agents, such as doxorubicin, fluorouracil, cytarabine, and docetaxel. HFS is c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2f5b92910e13cf4c4242bf528212d31
https://doi.org/10.1111/cup.14040
https://doi.org/10.1111/cup.14040
Autor:
Jessica Fleser, Bernard A. Fox, Annika Dalheim, David C. Murray, Chris Fountain, Constantine Godellas, Tamson V. Moore, Brendan D. Curti, Joseph I. Clark, Jodi Speiser, Siao Yi Wang, Michael I. Nishimura, Mallory Thomas, Matthew DeJong, Courtney Regan Wagner, Tarsem Moudgil, Gina Scurti, Kelli A. Hutchens
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 352-363 (2021)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
T cells that are gene-modified with tumor-specific T cell receptors are a promising treatment for metastatic melanoma patients. In a clinical trial, we treated seven metastatic melanoma patients with autologous T cells transduced to express a tyrosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8013b10b214b2316e2f365a86b70c5ea
http://www.sciencedirect.com/science/article/pii/S2372770521000152
http://www.sciencedirect.com/science/article/pii/S2372770521000152
Publikováno v:
Journal of Cutaneous Pathology. 47:675-680
BACKGROUND Objective methods for distinguishing melanoma in situ (MIS) from photodamaged skin (PS) are needed to guide treatment in patients with melanocytic proliferations. Melanocyte density (MD) could serve as an objective histopathological criter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b4ec0e5fb0129e98b650f6abb0cc6b
https://doi.org/10.1111/cup.13681
https://doi.org/10.1111/cup.13681